475 related articles for article (PubMed ID: 9690405)
1. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
4. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
5. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC
Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
[TBL] [Abstract][Full Text] [Related]
7. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
[TBL] [Abstract][Full Text] [Related]
8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
9. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.
Schulman LL; Weinberg AD; McGregor C; Galantowicz ME; Suciu-Foca NM; Itescu S
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1833-7. PubMed ID: 9620914
[TBL] [Abstract][Full Text] [Related]
10. The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures.
Jutte NH; Groeneveld K; Balk AH; Ouwehand AJ; Loonen EH; Van der Linden M; Strikwerda S; Mochtar B; Claas FH; Weimar W
Clin Exp Immunol; 1994 Oct; 98(1):158-62. PubMed ID: 7923876
[TBL] [Abstract][Full Text] [Related]
11. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease.
Stovin PG; Sharples LD; Schofield PM; Cary NR; Mullins PA; English TA; Wallwork J; Large SR
J Heart Lung Transplant; 1993; 12(1 Pt 1):110-6. PubMed ID: 8443188
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
[TBL] [Abstract][Full Text] [Related]
14. [The clinicopathological endomyocardial biopsy analysis in cardiac transplant recipients due to end-stage heart failure].
Li L; Zhao H; Wang HY; Lü FY; Liu L; Wang QZ; Si WX
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):819-21. PubMed ID: 17217692
[TBL] [Abstract][Full Text] [Related]
15. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
[TBL] [Abstract][Full Text] [Related]
16. Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens.
Costanzo-Nordin MR; Winters GL; Fisher SG; O'Sullivan J; Heroux AL; Kao W; Mullen GM; Johnson MR
J Heart Lung Transplant; 1993; 12(5):741-7. PubMed ID: 8241211
[TBL] [Abstract][Full Text] [Related]
17. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.
Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE
Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549
[TBL] [Abstract][Full Text] [Related]
18. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
19. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection.
Ramsperger-Gleixner M; Spriewald BM; Tandler R; Kondruweit M; Amann K; Weyand M; Ensminger SM
Exp Clin Transplant; 2011 Dec; 9(6):387-92. PubMed ID: 22142046
[TBL] [Abstract][Full Text] [Related]
20. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
Sheldon S; Hasleton PS; Yonan NA; Rhaman AN; Deiraniya AK; Campbell CS; Brooks NH; Dyer PA
Transplantation; 1994 Sep; 58(6):719-22. PubMed ID: 7940693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
